Akari Therapeutics' Nomacopan Is A Potential Blockbuster
November 09, 2023 at 09:50 AM EST
Nomacopan, a complement inhibitor with dual working, is a potential blockbuster with widespread use and already an established safety profile.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
